Variant report
Variant | esv2474625 |
---|---|
Chromosome Location | chr12:31773211-31774620 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr12:31773281-31773610 | HepG2 | liver: | n/a | n/a |
2 | BACH1 | chr12:31774389-31774449 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr12:31773359-31773551 | A549 | lung: | n/a | n/a |
4 | CEBPB | chr12:31773329-31773559 | HepG2 | liver: | n/a | n/a |
5 | EP300 | chr12:31773227-31773639 | HepG2 | liver: | n/a | chr12:31773563-31773573 |
6 | EP300 | chr12:31773394-31773509 | HepG2 | liver: | n/a | n/a |
7 | HDAC2 | chr12:31773309-31773603 | HepG2 | liver: | n/a | n/a |
8 | HNF4A | chr12:31773310-31773571 | HepG2 | liver: | n/a | n/a |
9 | HNF4A | chr12:31773308-31773555 | HepG2 | liver: | n/a | n/a |
10 | HNF4G | chr12:31773194-31773667 | HepG2 | liver: | n/a | chr12:31773307-31773322 chr12:31773307-31773322 |
11 | HNF4G | chr12:31773274-31773636 | HepG2 | liver: | n/a | chr12:31773307-31773322 chr12:31773307-31773322 |
12 | MAFF | chr12:31773263-31773564 | HepG2 | liver: | n/a | n/a |
13 | MAFK | chr12:31773283-31773560 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr12:31773263-31773540 | HepG2 | liver: | n/a | n/a |
15 | MXI1 | chr12:31773412-31773431 | HepG2 | liver: | n/a | n/a |
16 | POLR2A | chr12:31773297-31773623 | K562 | blood: | n/a | n/a |
17 | POLR2A | chr12:31773956-31774506 | K562 | blood: | n/a | n/a |
18 | RCOR1 | chr12:31773376-31773545 | HepG2 | liver: | n/a | n/a |
19 | RFX5 | chr12:31773512-31773523 | HepG2 | liver: | n/a | n/a |
20 | RFX5 | chr12:31774374-31774575 | K562 | blood: | n/a | n/a |
21 | SMC3 | chr12:31773412-31773564 | HepG2 | liver: | n/a | n/a |
22 | SP1 | chr12:31773226-31773680 | A549 | lung: | n/a | n/a |
23 | TEAD4 | chr12:31773150-31773648 | HepG2 | liver: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:31770731..31773142-chr12:31773203..31775587,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-METTL20-5 | chr12:31774007-31774266 | expReg_chr12_2804_+ |
No data |
No data |
Variant related genes | Relation type |
---|---|
AK4P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2625880 | chr12:31773248-31773249 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs59867670 | chr12:31773265-31773266 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs397816164 | chr12:31773275-31773276 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs11837587 | chr12:31773287-31773288 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs550253567 | chr12:31773302-31773303 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs377031964 | chr12:31773367-31773368 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs147429366 | chr12:31773389-31773390 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs564729809 | chr12:31773396-31773397 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs67161976 | chr12:31773409-31773410 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs551361397 | chr12:31773427-31773428 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs117715016 | chr12:31773445-31773446 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs549357035 | chr12:31773454-31773455 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs571387596 | chr12:31773465-31773466 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs187472333 | chr12:31773468-31773469 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs547580516 | chr12:31773469-31773470 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs192022166 | chr12:31773499-31773500 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs2679486 | chr12:31773506-31773507 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185043881 | chr12:31773518-31773519 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs139805814 | chr12:31773609-31773610 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs538667120 | chr12:31773642-31773643 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs558474865 | chr12:31773676-31773677 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs572214323 | chr12:31773736-31773737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs58670311 | chr12:31773758-31773759 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2625879 | chr12:31773762-31773763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565704482 | chr12:31773774-31773775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541206244 | chr12:31773793-31773794 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs189558432 | chr12:31773805-31773806 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554833687 | chr12:31773806-31773807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570151356 | chr12:31773812-31773813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370489745 | chr12:31773833-31773834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2617198 | chr12:31773847-31773848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs113799989 | chr12:31773932-31773933 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs367572056 | chr12:31773962-31773963 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs180910094 | chr12:31773972-31773973 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs376005502 | chr12:31773985-31773986 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs563986733 | chr12:31774010-31774011 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs532827474 | chr12:31774028-31774029 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs551400256 | chr12:31774029-31774030 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs533100980 | chr12:31774071-31774072 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs564831066 | chr12:31774126-31774127 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs541325935 | chr12:31774146-31774147 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs527271683 | chr12:31774156-31774157 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs74872615 | chr12:31774234-31774235 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs76506545 | chr12:31774245-31774246 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs72346724 | chr12:31774258-31774259 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs60028684 | chr12:31774262-31774263 | Enhancers Weak transcription | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs2049116 | chr12:31774283-31774284 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs73090522 | chr12:31774409-31774410 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569615445 | chr12:31774433-31774434 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs563580670 | chr12:31774446-31774447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cancer | 21129771 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17899364 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 20164920 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:31771200-31774600 | Enhancers | Fetal Intestine Large | intestine |
2 | chr12:31771400-31775400 | Enhancers | Fetal Intestine Small | intestine |
3 | chr12:31771600-31773600 | Enhancers | HepG2 | liver |
4 | chr12:31773000-31773600 | Enhancers | A549 | lung |
5 | chr12:31773600-31782600 | Weak transcription | A549 | lung |